COVID-19 Related Products

• 

  2019-nCoV(SARS-CoV-2)

  > 2019 nCoV Products-Antigens

  > 2019 nCoV Products-Antibody

  > 2019 nCoV ORF plasmids & viral particles

  > 2019 nCoV neutralizing antibody

  VIEW MORE>>

• 

  COVID-19 Vaccine & Antibody Candidates Efficacy Evaluation Solution 
  for new variants of SARS-CoV-2

  
  

  1. Products & inf collection of SARS-COV-2 (2019nCOV) Alpha variant (B.1.1.7),
  Beta variant (B.1.351), Gamma variant (B.1.1.28.1), Delta variant (B.1.617.2),
  Iota variant (B.1.526), and Double mutant variant B.1.617 lineage, S:E484Q+L452R (India) lineage
  2. Multiple variants of Spike protein&ACE2 competition binding assay
  Gamma variant (B.1.1.28.1), Alpha variant (B.1.1.7), 501Y.V2, N501Y, E484K, D614G, Trimer, RBD, etc)
  3. SARS-CoV2 Pseudovirus-Based Neutralization Assay System
  Gamma variant (B.1.1.28.1), Alpha variant (B.1.1.7), 501Y.V2, N501Y, E484K, D614G, Trimer, RBD, etc)
  4. Multi-Variants mammalian expression vector & Adenoviral vector
  Gamma variant (B.1.1.28.1), Alpha variant (B.1.1.7), 501Y.V2, N501Y, E484K, D614G, Trimer, RBD, etc)